Profile
Full Name
Vincerx Pharma, Inc.Ticker Symbol
VINCExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
May 27, 2020Indexes
Not includedWebsite
http://vincerx.comEmployees
12Key Details
Price
$0.27(+1.15%)
Market cap
$1.39M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$15.85(+57.98% YoY)
PE ratio
-
Next earnings date
May 14, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Vincerx Pharma doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Oct 8, 24 Leerink Partners
OutperformApr 9, 24 Cantor Fitzgerald
OverweightApr 1, 24 Cantor Fitzgerald
OverweightSep 7, 23 Cantor Fitzgerald
OverweightNov 17, 22 Chardan Capital
BuyAug 12, 22 SVB Leerink
OutperformJun 8, 22 Cantor Fitzgerald
OverweightJun 7, 22 SVB Leerink
OutperformJun 7, 22 Chardan Capital
BuyJun 7, 22 B. Riley Securities
BuyInstitutional Ownership
- What is the ticker symbol for Vincerx Pharma?
- Does Vincerx Pharma pay dividends?
- What sector is Vincerx Pharma in?
- What industry is Vincerx Pharma in?
- What country is Vincerx Pharma based in?
- When did Vincerx Pharma go public?
- Is Vincerx Pharma in the S&P 500?
- Is Vincerx Pharma in the NASDAQ 100?
- Is Vincerx Pharma in the Dow Jones?
- When was Vincerx Pharma's last earnings report?
- When does Vincerx Pharma report earnings?
- Should I buy Vincerx Pharma stock now?
What is the ticker symbol for Vincerx Pharma?
The ticker symbol for Vincerx Pharma is NASDAQ:VINC
Does Vincerx Pharma pay dividends?
No, Vincerx Pharma does not pay dividends
What sector is Vincerx Pharma in?
Vincerx Pharma is in the Healthcare sector
What industry is Vincerx Pharma in?
Vincerx Pharma is in the Biotechnology industry
What country is Vincerx Pharma based in?
Vincerx Pharma is headquartered in United States
When did Vincerx Pharma go public?
Vincerx Pharma's initial public offering (IPO) was on May 27, 2020
Is Vincerx Pharma in the S&P 500?
No, Vincerx Pharma is not included in the S&P 500 index
Is Vincerx Pharma in the NASDAQ 100?
No, Vincerx Pharma is not included in the NASDAQ 100 index
Is Vincerx Pharma in the Dow Jones?
No, Vincerx Pharma is not included in the Dow Jones index
When was Vincerx Pharma's last earnings report?
Vincerx Pharma's most recent earnings report was on Nov 12, 2024
When does Vincerx Pharma report earnings?
The next expected earnings date for Vincerx Pharma is May 14, 2025
Should I buy Vincerx Pharma stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions